Cargando…

Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma

Patients with papillary thyroid carcinoma (PTC) have excellent survival, but recurrence remains a major problem in the management of PTC. We aimed to determine the prognostic impact of the expression of CD10 and CD15 in patients with PTC. Immunohistochemistry for CD10 and CD15 was performed on the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Eun Ji, Bychkov, Andrey, Cho, Haejin, Kim, Tae-Min, Bae, Ja Seong, Lim, Dong-Jun, Jung, Chan Kwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352591/ https://www.ncbi.nlm.nih.gov/pubmed/32486143 http://dx.doi.org/10.3390/cancers12061413

Ejemplares similares

CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
por: Jeong, Young Mun, et al.
Publicado: (2020)

Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma
por: Kim, Yourha, et al.
Publicado: (2017)

Implications of isthmic location as a risk factor in papillary thyroid carcinoma
por: Kwon, Ohjoon, et al.
Publicado: (2023)

The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development
por: Jang, Tae Jung, et al.
Publicado: (2013)

Prognostic significance of CD133 and ABCB5 expression in papillary thyroid carcinoma
por: Karas Zella, Maria Augusta, et al.
Publicado: (2020)

Diagnostic value of CD-10 marker in differentiating of papillary thyroid carcinoma from benign thyroid lesions
por: Mokhtari, Mojgan, et al.
Publicado: (2014)

Atypical Histiocytoid Cells and Multinucleated Giant Cells in Fine-Needle Aspiration Cytology of the Thyroid Predict Lymph Node Metastasis of Papillary Thyroid Carcinoma
por: Choi, Ji Eun, et al.
Publicado: (2019)

Prognostic and Therapeutic Role of CD15 and CD15s in Cancer
por: Szlasa, Wojciech, et al.
Publicado: (2022)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology
por: Bychkov, Andrey, et al.
Publicado: (2018)

VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAF(V600E) Mutation in Papillary Thyroid Cancer
por: Choden, Sonam, et al.
Publicado: (2020)

Prognostic parameters for recurrence of papillary thyroid microcarcinoma
por: Kim, Tae Yong, et al.
Publicado: (2008)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

The Warthin-Like Variant of Papillary Thyroid Carcinoma: A Comparison with Classic Type in the Patients with Coexisting Hashimoto's Thyroiditis
por: Yeo, Min-kyung, et al.
Publicado: (2015)

Nomogram for the Prediction of Biochemical Incomplete Response in Papillary Thyroid Cancer Patients
por: Lim, Seung Taek, et al.
Publicado: (2021)

The role of prophylactic central compartment neck dissection in patients with T1–T2 cN0 papillary thyroid carcinoma
por: Kwon, Ohjoon, et al.
Publicado: (2023)

Classic Papillary Thyroid Carcinoma with Tall Cell Features and Tall Cell Variant Have Similar Clinicopathologic Features
por: Oh, Woo Jin, et al.
Publicado: (2014)

Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021)

Solitary Skin Metastasis of Papillary Thyroid Carcinoma
por: Kwon, Hyemi, et al.
Publicado: (2014)

Immune profiling identifies CD8(+) T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer
por: Chen, Zhen, et al.
Publicado: (2022)

Risk factors associated with high-risk nodal disease in patients considered for active surveillance of papillary thyroid microcarcinoma without extrathyroidal extension
por: Kwon, Ohjoon, et al.
Publicado: (2023)

Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age
por: Cho, Jin-Kyu, et al.
Publicado: (2012)

p63 inhibits CD44(+)/CD24(−) cell proliferation and chemoresistance in papillary thyroid carcinoma cells
por: Guo, Jing-Jing, et al.
Publicado: (2017)

P2X(7) Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto's Thyroiditis
por: Kwon, Ji Hyun, et al.
Publicado: (2014)

The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications
por: Rodrigues, Ana Cunha, et al.
Publicado: (2017)

Clinical Implication of Bilateral and Unilateral Multifocality in Papillary Thyroid Carcinoma: A Propensity Score-Matched Study
por: Kim, Youngmin, et al.
Publicado: (2023)

Prognostic and clinical significance of HOXC9 and HOXD10 in papillary thyroid cancer
por: Cao, Yi-Ming, et al.
Publicado: (2021)

The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma
por: Hong, Young Ran, et al.
Publicado: (2017)

CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions
por: Erdogan-Durmus, Senay, et al.
Publicado: (2016)

Emerging Biomarkers in Thyroid Practice and Research
por: Agarwal, Shipra, et al.
Publicado: (2021)

Predictive Factors for Skip Lymph Node Metastasis and Their Implication on Recurrence in Papillary Thyroid Carcinoma
por: Ryu, Young-Jae, et al.
Publicado: (2022)

Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial‐mesenchymal transition and cancer stem cell‐like properties
por: Lee, Sohee, et al.
Publicado: (2019)

Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
por: Jeon, Min Ji, et al.
Publicado: (2016)

Induction of IL-10-Producing CD1d(high)CD5(+) Regulatory B Cells following Babesia microti-Infection
por: Jeong, Young-Il, et al.
Publicado: (2012)

Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid
por: El Demellawy, Dina, et al.
Publicado: (2008)

PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment
por: Wang, Lingli, et al.
Publicado: (2022)

Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
por: Jeon, Min Ji, et al.
Publicado: (2016)

BRAF(V600E) Positivity-Dependent Effect of Age on Papillary Thyroid Cancer Recurrence Risk
por: Park, Joonseon, et al.
Publicado: (2023)

Development of a risk scoring system for patients with papillary thyroid cancer
por: Pak, Kyoungjune, et al.
Publicado: (2019)

Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
por: Kim, Sue Youn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_23jauj7b9nqma7auiksdl2qtog